A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Recruiting

Phase 2

BI 770371A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Sponsor:

Boehringer Ingelheim

Code:

NCT06675929

Conditions

Compensated Liver Cirrhosis

Metabolic Dysfunction Associated Steatohepatitis (MASH)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BI 770371

Placebo for BI 770371

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2025-04-16.